This study is a randomized double-blind placebo controlled trial that subject from women aged 20-50 years (premenopausal) and men 20-65 years with BMI=25-40 kg/m2 will be recruited from Sheykhorraeis clinic of Tabriz. The aim of the study is determining the effect of probiotic and conventional yoghurt consumption on metabolic status and serum hs-CRP level, leptin and paraoxonase 1 enzyme activity in patients with non-alcoholic fatty liver disease (NAFLD). Patients will be divided randomly to 2 groups; treatment and placebo. Treatment group receive 300 g of probiotic yoghurt 1.5% fat containing at least 107 cfu/g probiotic per day and placebo group 300 g of conventional yoghurt 1.5% fat for 8 weeks. Ultrasonography, Anthropometric measurements (weight, height), biochemical criteria including plasma level of Aspartat aminotransferase, Alanin aminotransferase,Total cholesterol, trigliceride, High density lipoprotein, Low density lipoprotein, Fasting blood glucose, Insulin resistance, Malondialdehyde, leptin hormone, hs-CRP and paraoxonase 1 enzyme activity appetite evaluation, 3 days of 24 hour food recall will be measured before and after treatment and will be compared between two groups.